Compare MGRX & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGRX | MRM |
|---|---|---|
| Founded | 2021 | 2000 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Other Consumer Services |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | 7.6M |
| IPO Year | 2023 | 2020 |
| Metric | MGRX | MRM |
|---|---|---|
| Price | $0.47 | $0.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 453.2K | 12.0K |
| Earning Date | 11-13-2026 | 10-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $456,021.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $32.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.26 | $0.60 |
| 52 Week High | $2.75 | $2.85 |
| Indicator | MGRX | MRM |
|---|---|---|
| Relative Strength Index (RSI) | 49.51 | 28.55 |
| Support Level | $0.34 | N/A |
| Resistance Level | $0.48 | $1.31 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 54.64 | 18.74 |
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.